ReleaseWire Connect

Traditional drug delivery methods such as powders, capsules, intravenous needles, liquids, and pills are often ineffective and might lead to side effects which are undesirable. Transdermal delivery comprises an effective and important route for delivery of new drug. These patches can be placed anywhere on the human body and it can be worn for as less as 7 hours to as long as one week, thereby depending on its therapeutic indication. The adhesive patches which are medicated ones are designed in such a way that they get themselves attached comfortably to the skin's surface, which helps the patients use the patches for a longer period of time.

The global helicobacter pylori (H. pylori) non-invasive testing market was valued at approximately US$ 518.0 Mn in 2017 and is projected to register a compounded annual growth rate (CAGR) of over 3.99% from 2018 to 2026, according to a new report titled, "Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026", published by Transparency Market Research (TMR) . The report suggests that factors, such as, rise in the adoption of non-invasive testing for diagnosis of H. pylori, lack of endoscopic facilities, and upcoming technologically-advanced tests from global market players for non-invasive helicobacter pylori testing in the next few years (2018-2026) are likely to boost the demand for global helicobacter pylori (H. pylori) non-invasive tests. High awareness and diagnosis rate of H. pylori infection in North America and high prevalence of the disease in East-European countries are likely to generate a significant share for the market in North America and Europe from 2018 to 2026.

The magnetic resonance imaging market has conventionally risen on the back of an advanced imaging technique, which has boosted adoption of the high-cost hardware, and software imaging. In turn, the advancement in the MRI imaging market continues to pave way for unimaginable possibilities in detection of several anomalies in critical organs like brain. Moreover, the prospect of the market remained limited earlier as CT imaging continued to be more cost-effective, and effective for applications like lung imaging. However, new products like Toshiba's new Ultrashort Echo Time (UTE) enables clinicians to view high susceptibility regions, where conventionally the MR imaging signal used to disappear. Advanced products like this, and GE Healthcare's MAGiC, promise lower turnaround times for MRI imaging, which is critical in care for chronic diseases, and rising elderly population.

Ventricular tachycardia is a condition, wherein the pulse rate is more than 100 beats per minute with minimum three continuous irregular heartbeats. This condition occurs in bottom chambers of the heart and develops as an early or late complication of heart attack. Patients suffering from cardiomyopathy, myocarditis, or valvular heart disease are at a higher risk of developing ventricular tachycardia. Major reasons for ventricular tachycardia are changes in pH values, changes in blood chemistry, and lack of oxygen. If the heart rate during this condition is very high and lasts for longer time, the patient may complain of chest discomfort, fainting, palpitation, dizziness, or shortness of breath. If left untreated, it leads to ventricular fibrillation (a leading cause of cardiac death).

The global automotive laser headlight market is projected to surpass US$ 18.9 Bn by 2030, expanding at a CAGR of ~27% during the forecast period.

The global advanced driver assistance system market is projected to surpass US$ 150 Bn by 2027, expanding at a CAGR of above 12% during the forecast period.

The global tire market for automotive is projected to surpass US$ 190 Bn by 2027, expanding at a CAGR of above 3% during the forecast period.

The global autonomous trains market was at 8,000 Km in 2018 and is projected to surpass 29,000 Km by 2028 at a CAGR of around 13% from 2018 to 2027.

The farm tractor market in the region is estimated to expand at a CAGR of 3.88 % during the forecast period from 2019 to 2027.

Global GMP Cell Banking Services Market: Overview